Darrell J. Triulzi, MD
Dr. Triulzi is the Director of the Division of Transfusion Medicine, Department of Pathology and Medical Director, Institute for Transfusion Medicine. Dr Triulzi serves as the division leader in transfusion medicine. The division provides clinical transfusion support to the UPMC health system hospitals and is actively involved in its Patient Blood Management Program. Dr Triulzi leads a robust clinical research program in the division.
Professor of Pathology
Institute for Transfusion Medicine
3636 Blvd. of the Allies
Pittsburgh, PA 15213
Office Telephone: 412-209-7304
- MD - Albany Medical College, 1985
Clinical ExpertiesDr. Triulzi has general expertise in the area of transfusion medicine with particular clinical and research expertise in transfusion support of organ and stem cell transplant patients. He is highly involved both locally and nationally in Patient Blood Management and its application to orthopedic surgery, cardiac surgery and trauma.
Research InterestsDr Triulzi has held numerous grants in the area of transfusion medicine and currently serves as PI on the NIH Transfusion Medicine Hemostasis Clinical Trials grant and the NIH REDSIII grant. His interests include adverse effects of transfusion, the red cells storage lesion and epidemiologic studies of transfusion. He serves as Co-PI on the NIH multicenter RECESS study of age of blood in cardiac surgery.
Selected PublicationsView Dr. Triulzi's publications on PubMed
Yazer MH, Raval JS, Triulzi DJ, Blumberg N. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets. Vox Sang 2012;102:93-184.
Radkay L, DJ Triulzi, MH Yazer. Low risk of hemolysis following transfusion of uncrossmatched RBCs. Immunohematology 2012;28:39-44.
Narick C, Triulzi DJ, Yazer MH. Transfusion Associated Circulatory Overload Following Plasma Transfusion. Transfusion 2012;52:160-165.
Triulzi DJ, Assmann SF, Strauss RG, Ness PM, Hess JR, Kaufman RM, Granger S, Slichter SJ. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood 2012;119:5553-5562.
Blajchman MA, Carson JL, Eikelboom JW, Heddle NM, Lacroix J, Lauer MS, Platt R, Tilley B, Triulzi DJ, et al. The role of comparative effectiveness research in Transfusion Medicine trials: proceedings of a National Heart Lung and Blood Institute workshop. Transfusion 2012;52:1363-68.
Yazer MH, Triulzi DJ Anti-D alloimmunization propensity cannot be determined without information on D antigen exposure(letter). Transfusion 2012:52:2069-70.
Wang, RR, Triulzi, DJ, Qu, L. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol. 2012;138(2):255-9.
Raval JS, waters JH, Triulzi DJ, Yazer MH. Complications following an unnecessary peri-operative plasma transfusion and literature review. Korean J Hematology 2012;47:298-301.
Gottschall J, Triulzi D, Kakaiya R et al. NHLBI REDSII. Human neutrophil antibodies in a blood donor population: a lookback study. Vox Sang 2013;104:166-70.
Kaufman RM, Schlumpf KS, Wright DJ, Triulzi DJ; NHLBI Retrovirus Epidemiology Donor Study-II. Does Rh immune globulin suppress HLA sensitization in pregnancy? Transfusion. 2013;53(9):2069-77
Raval JS, Nelson JB, Woldemichael, Triulzi DJ. Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012;52:2590-3.
McWilliams B, Yazer MH, Cramer J, Triulzi DJ, Waters JH. Incomplete pre-transfusion testing leads to surgical delays. Transfusion 2012 52(10):2139-44.
McDaniel LM, Neal MD, Sperry JL, Alaracon LH, Forsythe RM, Triulzi D, Peitzman AB, Raval JS. Use of a massive transfusion protocol in non-trauma patients; activate away. J Am Coll Surg 2013;216:1103-9.
Harm SK, Delaney M, Charapata M, Aubuchon JP, Triulzi DJ, Yazer MH. Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood-derived platelets. Transfusion. 2013 Apr;53(4):843-50.
Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ et al, Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013;165:964-71.
Berg A, Courtney R, Krishnamurti L, Triulzi DJ, Yazer MH. Is intensive monitoring during the first transfusion in pediatric patients necessary? Hematology 2014 Jul;19(5):304-8
Yazer MH, Triulzi DJ, Reddy V, Waters JH. Effectiveness of a real-time clinical decision support system for computerized physician order entry of plasma orders. Transfusion. 2013;53:3120-7.
Collins RA, Triulzi DJ, Waters JH, Reddy V, Yazer MH. Evaluation of Real-Time Clinical Decision Support Systems for Platelet and Cryoprecipitate Orders. Am J Clin Pathol 2014; 141(1):78-84.
Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol. 2014 Feb;141(2):256-61.
McWilliams B, Triulzi DJ, Waters JH, Alarcon LH, Reddy V, Yazer MH. Trends in RBC ordering and use after implementing adaptive alerts in the electronic computerized physician order entry system. Am J Clin Pathol. 2014 Apr;141(4):534-41